• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

目前对肽基精氨酸脱亚氨酶(PAD)酶家族在心血管疾病中的作用的认识。

Current knowledge into the role of the peptidylarginine deiminase (PAD) enzyme family in cardiovascular disease.

机构信息

Department of Physiology and Biochemistry, Faculty of Medicine, Jordan University of Science and Technology, Irbid, 22110, Jordan.

Department of Pharmacology and Physiology, Université de Montréal, Montreal, Quebec, Canada; Montreal Heart Institute, Université de Montréal, Montreal, Quebec, Canada; Department of Medicine, Université de Montréal, Montreal, Quebec, Canada; Department of Biochemistry and Molecular Medicine, Université de Montréal, Montreal, Quebec, Canada.

出版信息

Eur J Pharmacol. 2021 Jan 15;891:173765. doi: 10.1016/j.ejphar.2020.173765. Epub 2020 Nov 26.

DOI:10.1016/j.ejphar.2020.173765
PMID:33249073
Abstract

Peptidylarginine deiminase (PAD) family members have a vital role in maintaining the stability of the extracellular matrix (ECM) during remodelling in several heart diseases. PAD-mediated deamination, or citrullination, has been studied in different physiological and pathological conditions in the body. However, the role of PAD isoforms has not been fully studied in cardiovascular system. Citrullination is a post-translational modification that involves conversion of peptidyl-based arginine to peptidyl-based citrulline by PAD family members in a calcium-dependent manner. Upregulation of PADs have been observed in various cardiovascular diseases, including venous thrombosis, cardiac fibrosis, heart failure, atherosclerosis, coronary heart disease and acute inflammation. In this review, experimental aspects of in vivo and in vitro studies related to the roles PAD isoforms in cardiovascular diseases including mechanisms, pathophysiological and therapeutic properties are discussed. Pharmacological strategies for targeting PAD family proteins in cardiac diseases have not yet been studied. Furthermore, the role played by PAD family members in the remodelling process during the progression of cardiovascular diseases is not fully understood.

摘要

肽基精氨酸脱亚氨酶(PAD)家族成员在几种心脏病 remodelling 过程中对维持细胞外基质(ECM)的稳定性起着至关重要的作用。PAD 介导的脱氨作用,或瓜氨酸化,已在体内不同的生理和病理条件下进行了研究。然而,PAD 同工酶在心血管系统中的作用尚未得到充分研究。瓜氨酸化是一种翻译后修饰,涉及 PAD 家族成员以钙依赖性方式将基于肽的精氨酸转化为基于肽的瓜氨酸。在各种心血管疾病中,包括静脉血栓形成、心脏纤维化、心力衰竭、动脉粥样硬化、冠心病和急性炎症,都观察到 PAD 的上调。本综述讨论了与 PAD 同工酶在心血管疾病中的作用相关的体内和体外研究的实验方面,包括机制、病理生理和治疗特性。尚未研究针对心脏疾病中 PAD 家族蛋白的药理学策略。此外,PAD 家族成员在心血管疾病进展过程中的重塑过程中所扮演的角色还不完全清楚。

相似文献

1
Current knowledge into the role of the peptidylarginine deiminase (PAD) enzyme family in cardiovascular disease.目前对肽基精氨酸脱亚氨酶(PAD)酶家族在心血管疾病中的作用的认识。
Eur J Pharmacol. 2021 Jan 15;891:173765. doi: 10.1016/j.ejphar.2020.173765. Epub 2020 Nov 26.
2
Role of protein deimination in cardiovascular diseases: potential new avenues for diagnostic and prognostic biomarkers.蛋白质脱亚氨基作用在心血管疾病中的作用:诊断和预后生物标志物的新潜在途径。
Expert Rev Proteomics. 2021 Dec;18(12):1059-1071. doi: 10.1080/14789450.2021.2018303. Epub 2022 Jan 12.
3
Protein Arginine Deiminases (PADs): Biochemistry and Chemical Biology of Protein Citrullination.蛋白精氨酸脱亚氨酶(PADs):蛋白质瓜氨酸化的生化和化学生物学。
Acc Chem Res. 2019 Mar 19;52(3):818-832. doi: 10.1021/acs.accounts.9b00024. Epub 2019 Mar 7.
4
Citrullination and PAD Enzyme Biology in Type 1 Diabetes - Regulators of Inflammation, Autoimmunity, and Pathology.1 型糖尿病中瓜氨酸化和 PAD 酶生物学——炎症、自身免疫和病理的调节剂。
Front Immunol. 2021 Jun 1;12:678953. doi: 10.3389/fimmu.2021.678953. eCollection 2021.
5
Peptidylarginine deiminase (PAD): A promising target for chronic diseases treatment.肽基精氨酸脱亚氨酶(PAD):一种有前途的慢性疾病治疗靶点。
Int J Biol Macromol. 2024 Oct;278(Pt 3):134576. doi: 10.1016/j.ijbiomac.2024.134576. Epub 2024 Aug 9.
6
An interplay of structure and intrinsic disorder in the functionality of peptidylarginine deiminases, a family of key autoimmunity-related enzymes.在肽基精氨酸脱亚氨酶家族(一组与自身免疫相关的关键酶)的功能中,结构和固有无序相互作用。
Cell Mol Life Sci. 2019 Dec;76(23):4635-4662. doi: 10.1007/s00018-019-03237-8. Epub 2019 Jul 24.
7
Discovery of Novel Potential Reversible Peptidyl Arginine Deiminase Inhibitor.新型潜在可逆转肽基精氨酸脱亚氨酶抑制剂的发现。
Int J Mol Sci. 2019 May 2;20(9):2174. doi: 10.3390/ijms20092174.
8
Insights into peptidylarginine deiminase expression and citrullination pathways.关于肽基精氨酸脱亚氨酶表达和瓜氨酸化途径的研究进展。
Trends Cell Biol. 2022 Sep;32(9):746-761. doi: 10.1016/j.tcb.2022.01.014. Epub 2022 Feb 21.
9
Chemical biology of protein citrullination by the protein A arginine deiminases.蛋白质精氨酸脱亚氨酶介导的蛋白质瓜氨酸化的化学生物学
Curr Opin Chem Biol. 2021 Aug;63:19-27. doi: 10.1016/j.cbpa.2021.01.010. Epub 2021 Mar 4.
10
Methods for the detection of peptidylarginine deiminase (PAD) activity and protein citrullination.检测肽基精氨酸脱亚氨酶(PAD)活性和蛋白质瓜氨酸化的方法。
Mol Cell Proteomics. 2014 Feb;13(2):388-96. doi: 10.1074/mcp.R113.033746. Epub 2013 Dec 2.

引用本文的文献

1
N-acetylglucosaminyltransferase V attenuates myocardial infarction by mediating the insulin-like growth factor 1 receptor signaling pathway.N-乙酰葡糖胺基转移酶V通过介导胰岛素样生长因子1受体信号通路减轻心肌梗死。
J Transl Int Med. 2025 Jun 20;13(3):281-294. doi: 10.1515/jtim-2025-0021. eCollection 2025 Jun.
2
Crossing epigenetic frontiers: the intersection of novel histone modifications and diseases.跨越表观遗传学前沿:新型组蛋白修饰与疾病的交汇点。
Signal Transduct Target Ther. 2024 Sep 16;9(1):232. doi: 10.1038/s41392-024-01918-w.
3
Atrial cardiomyocytes contribute to the inflammatory status associated with atrial fibrillation in right heart disease.
右心疾病相关的心房颤动与心房肌细胞导致的炎症状态有关。
Europace. 2024 Mar 30;26(4). doi: 10.1093/europace/euae082.
4
Proteomics of the heart.心脏蛋白质组学。
Physiol Rev. 2024 Jul 1;104(3):931-982. doi: 10.1152/physrev.00026.2023. Epub 2024 Feb 1.
5
Implications for neutrophils in cardiac arrhythmias.中性粒细胞在心律失常中的意义。
Am J Physiol Heart Circ Physiol. 2024 Mar 1;326(3):H441-H458. doi: 10.1152/ajpheart.00590.2023. Epub 2023 Dec 15.
6
The effect of HLA-DRB1*04:01 on a mouse model of atherosclerosis.HLA-DRB1*04:01对动脉粥样硬化小鼠模型的影响。
J Transl Autoimmun. 2023 Jun 21;7:100203. doi: 10.1016/j.jtauto.2023.100203. eCollection 2023 Dec.
7
Current insights into the role of citrullination in thrombosis.目前对瓜氨酸化在血栓形成中的作用的认识。
Curr Opin Chem Biol. 2023 Aug;75:102313. doi: 10.1016/j.cbpa.2023.102313. Epub 2023 May 4.
8
Non-Coding RNAs in Regulating Plaque Progression and Remodeling of Extracellular Matrix in Atherosclerosis.非编码 RNA 在调控动脉粥样硬化斑块进展和细胞外基质重塑中的作用。
Int J Mol Sci. 2022 Nov 8;23(22):13731. doi: 10.3390/ijms232213731.
9
Novel Peptidylarginine Deiminase Type 4 (PAD4) Inhibitors.新型4型肽基精氨酸脱亚氨酶(PAD4)抑制剂。
ACS Med Chem Lett. 2022 Sep 6;13(10):1537-1538. doi: 10.1021/acsmedchemlett.2c00387. eCollection 2022 Oct 13.
10
Evidence of Failed Resolution Mechanisms in Arrhythmogenic Inflammation, Fibrosis and Right Heart Disease.心律失常性炎症、纤维化和右心疾病中失败的解决机制的证据。
Biomolecules. 2022 May 19;12(5):720. doi: 10.3390/biom12050720.